Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638

Vaccine

Volumn 24, Issue 18, 2006, Pages 3746-3749

  Talavera, A ^a   Ano G ^a   Garcia H ^a   Moreira, T ^b   Delgado, H ^b   Riveron L ^a   Gil, S ^a   Miranda, A ^a   Cedre B ^a   Valmaseda, T ^a   Pino, Y ^a   Perez J L ^a   Infante, J F ^a   Garcia L ^a   Sierra, G ^a  

^a FINLAY INSTITUTE   (Cuba)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

Cholera; Process; Vaccine

Indexed keywords

CHOLERA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CHOLERA; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; FERMENTATION TECHNIQUE; FREEZE DRYING; IMMUNOGENICITY; INFECTION PREVENTION; LARGE SCALE PRODUCTION; MICROBIAL BIOMASS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RABBIT; STATISTICAL MODEL; VACCINE PRODUCTION; VIBRIO CHOLERAE;

ANIMALS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; DRUG INDUSTRY; FERMENTATION; HUMANS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; TECHNOLOGY, PHARMACEUTICAL; VACCINES, ATTENUATED; VIBRIO CHOLERAE;

EID: 33748186135     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.015     Document Type: Article

References (17)

1. WHO. Initiative for Vaccine Research (IVR). State of the art of new vaccines: research and development. 2002.
2. Keddy KH. Cholera update. Communicable Diseases Surveillance Bulletin, NICD, 2004. March.
3. Calaine P., Chaine J.-P., Johnson E., Hawley M.-L., O'Leary M., Oshitani H., et al. Can oral cholera vaccination play a role in controlling a cholera outbreak?. Vaccine 22 (2004) 2444-2451
4. Lucas M.E., Deen J.L., von Sedlein L., Wang X.Y., Ampuero J., Puri M., et al. Effectiveness of mass cholera vaccination in Beira, Mozambique. N Eng J Med 352 (2005) 757-767
5. Benitez J., Garcia L., Silva A., Garcia H., Fando R., Cedré B., et al. Preliminary assessment of the safety and immunogenicity of a new CTXφ{symbol}-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun 67 2 (1999) 539-545
6. García L, Fando R, Díaz M, García H, Rodríguez B, Fernández R, et al. Controlled volunteer challenge study to protective efficacy of a single oral dose of strain Vibrio cholerae, a Cuban cholera vaccine candidate. Vaccine for enteric diseases, Montego Bay, Jamaica: April 2004; 28-30.
7. Talavera A., Moreira T., Año G., Cedré B., Delgado H., García H., et al. Viabilidad in vitro y colonización en ratones neonatos de una formulación vacunal de la cepa 638 de Vibrio cholerae. Revista CENIC 31 2 (2000) 110-112
8. Richardson K. Roles of motility and flagella structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in th ere animal models. Infect Immun 59 (1991) 2727-2736
9. OPS/OMS/CDC/NCID.Curso de Métodos de Laboratorio en el diagnóstico de Vibrio cholerae. Procedimientos de laboratorio. Caracas, Venezuela: Octubre 1994; 22-25.
10. Cedré B., García H., Fariñas M., Talavera A., and Infante J.F. Intestinal colonization of the infant mouse model by attenuated and Vibrio cholerae strain. Arch Med Res 29 3 (1998) 231-234
11. Vacca L.L. Laboratory Manual of Histochemestry (1985), Raven Press Books, New York
12. Morris J.G., Losonsky G.E., Johnson J.A., Tacket C.O., Nataro J.P., Panigrahi P., et al. Clinical and immunological characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis 171 (1995) 903-908
13. Ichinose Y., Yamamoto K., Nakanose N., Tanabe N.J., Takeda T., Miwanati T.K., et al. Enterotoxicity of the El Tor-like hemolisin of non-O1 Vibrio cholerae. Infect Immun 55 (1987) 1090-1095
14. García L., Oliva R., Cedré B., Valmaseda T., García H., Talavera A., et al. Intraduodenal inoculation of adult rabbit for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. Lab Animal Sci 48 6 (1998) 538-541
15. Cedré B., Viel Y., Rodríguez T., Año G., Pino Y., García H., et al. Validation of colorimetric vibriocidal assay to determine serum antibodies against vaccine candidate strains of Vibrio cholerae. Vaccimonitor 12 1 (2003) 23-30
16. Pino Y., Valmaseda T., Medina Y., Cedré B., Año G., García H., et al. Validation of an ELISA assay to determine antibodies against LPS of Vibrio cholerae. Vaccimonitor 12 1 (2003) 11-17
17. Robert A., Silva A., Benítez J.A., Rodríguez B.L., Fando R., Campos J., et al. Taggin a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin protease gene using a novel reporter enzime. Clostridium Thermocellone Endogluconase A: Vaccine 14 (1996) 1517-1522